Compared with seropositive controls, ORadj (95% CI) of NPC was 65.56 (47.40‐90.68) and 91.19 (63.48‐130.99), respectively, for anti‐EBV VCA IgA and anti‐EBV EA‐EBNA1 IgA. Here, CD79A is linked to nasopharyngeal carcinoma.